CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Coronary Orbital Atherectomy plus Stentingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02339545
NCT02339545N/ACompleted
CompareCT.gov

Coronary Flow Reserve Following Orbital Atherectomy and Percutaneous Revascularization in Severely Calcified Coronary Lesions

Abbott Medical Devices·observational·Posted Jan 15, 2015·Updated Jul 18, 2023

In Brief

An observational study evaluating Coronary Orbital Atherectomy plus Stenting for Coronary Artery Disease. Completed, enrolled 15 participants across 3 sites.

Detailed Summary

The purpose of the study was to evaluate coronary artery flow reserve (CFR) following successful percutaneous coronary intervention (PCI) treatment of severely calcified coronary lesions by orbital atherectomy and stenting.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJan 15, 2015
Enrollment StartFeb 1, 2015
Primary CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 11.5 years ago

Interventions

Coronary Orbital Atherectomy plus Stentingdevice